Fujiko Morita Yuji Hirai Kiyozumi Suzuki Yuki Uehara Kazunori Mitsuhashi Masahito Takahashi Sumio Watanabe Toshio Naito
10.2169/internalmedicine.56.8245
Intern Med
2017;56(15):2039-2042.
gram stain pseudomonas aeruginosa bacteremic pneumonia pegfilgrastim solid cancer
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28768977/
Filgrastim / adverse effects Pneumonia, Bacterial / diagnostic imaging Polyethylene Glycols / adverse effects Pseudomonas Infections / diagnostic imaging
Filgrastim / adverse effects Pneumonia, Bacterial / diagnostic imaging Polyethylene Glycols / adverse effects Pseudomonas Infections / diagnostic imaging Case Reports Aged Anti-Bacterial Agents / therapeutic use Antineoplastic Agents / adverse effects Antineoplastic Agents / therapeutic use Bacteremia / diagnostic imaging Bacteremia / drug therapy Bacteremia / immunology Filgrastim / therapeutic use Humans Immunocompromised Host Male Neutropenia / chemically induced Neutropenia / prevention & control Pancreatic Neoplasms / drug therapy Pneumonia, Bacterial / drug therapy Pneumonia, Bacterial / immunology Polyethylene Glycols / therapeutic use Pseudomonas Infections / drug therapy Pseudomonas Infections / immunology Radiography Recombinant Proteins / adverse effects Recombinant Proteins / therapeutic use Tomography, X-Ray Computed Anti-Bacterial Agents Antineoplastic Agents Recombinant Proteins pegfilgrastim Polyethylene Glycols Filgrastim
PMC5577083
28768977
The First Case of Pseudomonas aeruginosa Bacteremic Pneumonia in a Cancer Patient Receiving Pegfilgrastim
2017